STABILIZED CHEWABLE ANTIMICROBIAL ANIMAL FOODSTUFF
    133.
    发明公开
    STABILIZED CHEWABLE ANTIMICROBIAL ANIMAL FOODSTUFF 失效
    企稳,咀嚼片,抗菌宠物食品。

    公开(公告)号:EP0658096A1

    公开(公告)日:1995-06-21

    申请号:EP93921221.0

    申请日:1993-08-27

    IPC分类号: A61K38

    摘要: The invention is an animal chew which contains one or more enzymes and substrates for the purpose of generating antimicrobial compounds upon contact with an animal's saliva. The animal chew, made of rawhide, biscuit or dried animal food is provided with an oxidoreductase enzyme and substrate, such as, for example, glucose oxidase and glucose, which produces hydrogen peroxide upon being chewed. A catalase may be provided to stabilize the system and prevent premature activation of the enzyme/substrate system. A peroxidase and halide or pseudohalide ion combination may be provided to enhance the antimicrobial effect of the invention.

    Insoluble crosslinked cytotoxic oxidase-peroxidase system
    136.
    发明公开
    Insoluble crosslinked cytotoxic oxidase-peroxidase system 失效
    不溶性交联的细胞毒性氧化酶 - 过氧化物酶系统。

    公开(公告)号:EP0062434A1

    公开(公告)日:1982-10-13

    申请号:EP82301451.9

    申请日:1982-03-19

    申请人: Kiel, Jonathan L

    发明人: Kiel, Jonathan L

    IPC分类号: C12N11/18 A61K37/50

    摘要: A therapeutic preparation, and a process of using the preparation, for the control of tumour growth and infectious diseases. The preparation is an immobilized cytotoxic enzyme system which is carried by an insoluble substrate that is administered into the mammalian subject by injection or implantation. The preferred embodiment of the preparation uses a polymerized albumin carrier containing immobilized glucose oxidase and peroxidase. The immobilized enzyme system is prepared in the form of small particles that can be administered either by implantation or by injection into tumour-bearing mammals. To date, antibacterial activity has been demonstrated only in vitro. Intraperitoneal injection into rats bearing Novikoff hepatomas or into mice bearing B16-Fl melanomas or L1210 (Lymphoid) tumours has resulted in the selected killing of tumour tissues. Several daily administrations are required to achieve complete destruction of the tumour. Additionally, the preparation is also active as a stimulant of the specific immune response to neoplasia. Its effect on the immune system could be useful in the stimulation of the immune system in diseases where the action of the endogenous immune system is insufficient.